April 16 (Reuters) - Novartis Pharmaceuticals Canada Inc:
* NOVARTIS PHARMACEUTICALS CANADA INC. - HEALTH CANADA APPROVES AN EXTENDED INDICATION FOR KISQALI (RIBOCICLIB) IN COMBINATION TREATMENT
April 16 (Reuters) - Novartis Pharmaceuticals Canada Inc:
* NOVARTIS PHARMACEUTICALS CANADA INC. - HEALTH CANADA APPROVES AN EXTENDED INDICATION FOR KISQALI (RIBOCICLIB) IN COMBINATION TREATMENT